Filing Details
- Accession Number:
- 0001061983-17-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-03 20:26:38
- Reporting Period:
- 2017-11-01
- Accepted Time:
- 2017-11-03 20:26:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1288859 | I Robert Blum | 280 East Grand Avenue South San Francisco CA 94080 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-11-01 | 500 | $13.10 | 70,180 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 100 | $13.15 | 70,080 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 200 | $13.38 | 69,880 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 1,100 | $13.40 | 68,780 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 100 | $13.43 | 68,680 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 200 | $13.55 | 68,480 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 100 | $13.58 | 68,380 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 1 | $13.58 | 68,379 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 1,000 | $13.60 | 67,379 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 1,000 | $13.65 | 66,379 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 100 | $13.68 | 66,279 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 347 | $13.70 | 65,932 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-01 | 252 | $13.80 | 65,680 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,083 | Indirect | by Trust 1 |
Common Stock | 2,083 | Indirect | by Trust 2 |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017.
- Shares held by The Bridget Blum 2003 Irrevocable Trust.
- Shares held by The Brittany Blum 2003 Irrevocable Trust.